CliffBio
small molecule

POTASSIUM CHLORIDE 20MEQ

POTASSIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM CHLORIDE 20MEQ
Active ingredientPOTASSIUM CHLORIDE
Strength1.49GM/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2021
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.